Filing Flows › Viatris (VTRS) › Q3 2025
Viatris (VTRS) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 6, 2025
Viatris (VTRS) reported revenue of $3.8B for the third quarter 2025 (Q3 2025), +0.2% from a year earlier and +5% from the quarter before. Operating margin was 4.8%, net loss $128M (3.4% of revenue).
Viatris, Q3 2025: revenue $3.8B (+0.2% year over year), operating margin 4.8%, net loss $128M, operating cash flow $745M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.8B | +5% | +0.2% |
| Operating profit | $179M | -23% | — |
| Net earnings | −$128M | — | — |
| Operating cash flow | $745M | +239% | -10% |
| Free cash flow | $658M | +295% | -12% |
What changed
Revenue was $3.8B in Q3 2025, roughly flat year over year and up 5% from the previous quarter. Brands was the largest line at 65% of revenue. Brands added $0.07B year over year (up 3%), 857% of the total change. Lyrica ® declined 3%.
Gross margin was 36.5%, down 2.4 points from a year earlier. Operating profit was $0.18B, a 4.8% margin (down 1.3 points year over year). Operating profit fell $0.05B even though revenue rose $0.01B versus a year earlier, so costs grew faster than sales. Operating expenses fell 3% while revenue was flat. The fastest-growing cost line was Other operating costs (+77%). The quarter ended with a net loss of $0.13B, wider than the previous quarter's $4.6M loss. Net interest and other expense of $0.19B was the main reason.
Operating cash flow was $0.74B (down 10% year over year). Non-cash charges added back $0.69B of depreciation and amortization and $0.04B of share-based compensation. Working capital and other items added $0.15B. Capital expenditures of $0.09B left free cash flow of $0.66B.
Questions
What was Viatris' revenue in the third quarter 2025?
Viatris (VTRS) reported revenue of $3.8B for the third quarter 2025 (Q3 2025), +0.2% from a year earlier and +5% from the quarter before.
Was Viatris profitable in the third quarter 2025?
Operating profit was $179M (4.8% of revenue) and net loss $128M.
Source: Viatris 10-Q on SEC EDGAR.